LBPH Company Profile and Key Details
Longboard Pharmaceuticals, Inc.
LBPH Stock Price Chart
Stock Price Today
Longboard Pharmaceuticals, Inc. (LBPH) stock remained unchanged at -, trading at $59.98 on NASDAQ, unchanged from the previous close of -. The stock opened at -, fluctuating between $59.98 and $59.98 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.
Company Information
| Employees | 50 |
| Beta | 1.09 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) stock price is $59.98 in the last trading session. During the trading session, LBPH stock reached the peak price of $59.98 while $59.98 was the lowest point it dropped to. The percentage change in LBPH stock occurred in the recent session was N/A while the dollar amount for the price change in LBPH stock was -.
The NASDAQ listed LBPH is part of Biotechnology industry that operates in the broader Healthcare sector. Longboard Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Steven W. Spector J.D.
Executive Vice President, Head of Bus. Devel. & Gen. Counsel
Mr. Kevin R. Lind
Pres, Chief Executive Officer, Sec. & Director
Gus Cardenas
Vice President & Head of Quality Assurance
Dr. Marco Peters Ph.D.
Vice President & Head of Translational Science
Dr. Anne M. Danks
Vice President & Head of Preclinical Devel.
Mr. Chadwick J. Orevillo MPH
Executive Vice President & Head of Operations
Ms. Brandi L. Roberts CPA, M.B.A.
Consultant
Megan E. Knight
Head of Investor Relations
Dr. Jodi Parsons
Vice President & Head of Regulatory Affairs
Dr. Randall E. Kaye M.D.
Executive Vice President & Chief Medical Officer
Dr. Anne M. Danks Ph.D.
Vice President & Head of Nonclinical Devel.
Mr. Gus Cardenas
Vice President & Head of Quality Assurance
LBPH's closing price is 0% higher than its 52-week low of $59.98 where as its distance from 52-week high of $59.98 is 0%.
Number of LBPH employees currently stands at 50.
Official Website of LBPH is: https://www.longboardpharma.com
LBPH could be contacted at phone 619 592 9775 and can also be accessed through its website. LBPH operates from 4275 Executive Square, La Jolla, CA 92037, United States.
LBPH stock volume for the day was 0 shares. The average number of LBPH shares traded daily for last 3 months was 0.
The market value of LBPH currently stands at $2.34B with its latest stock price at $59.98 and 39.05M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com